OBJECTIVES: Medical male circumcision (MMC) is recommended for HIV prevention in men. We assessed the acceptability and safety of the Shang Ring device compared with those of the dorsal slit method. METHODS: HIV-negative, uncircumcised men aged 18 years or older who requested free MMC services in rural Rakai, Uganda, were informed about the Shang Ring and dorsal slit procedures and offered a free choice of procedure. Men were followed at 7 days postoperatively to assess adverse events related to surgery and to remove the Shang Ring. Wound healing was assessed at 4 weeks postoperatively. RESULTS: Six hundred twenty-one men were enrolled, of whom 508 (81.8%) chose the Shang Ring and 113 the dorsal slit. The Shang Ring was provided to 504 men, among whom there were 4 failures of Ring placement (0.8%) that required surgical hemostasis and wound closure. Five hundred men received the Shang Ring and postoperative surgery-related moderate adverse events were 1.0%, compared with 0.8% among dorsal slit recipients. Complete wound healing at 4 weeks was 84% with the Ring and 100% with the dorsal slit (P < 0001). Resumption of intercourse before 4 weeks was 7.0% with the Ring and 15.0% with the dorsal slit (P = 0.01.) The mean time for surgery was 6.1 minutes with the Ring and 17.7 minutes with the dorsal slit. The mean time for Ring removal was 2.2 minutes. CONCLUSIONS: The Shang Ring is highly acceptable and safe in this setting, and could improve the efficiency of MMC services. However, back-up surgical services are needed in cases of Ring placement failures.
OBJECTIVES: Medical male circumcision (MMC) is recommended for HIV prevention in men. We assessed the acceptability and safety of the Shang Ring device compared with those of the dorsal slit method. METHODS:HIV-negative, uncircumcised men aged 18 years or older who requested free MMC services in rural Rakai, Uganda, were informed about the Shang Ring and dorsal slit procedures and offered a free choice of procedure. Men were followed at 7 days postoperatively to assess adverse events related to surgery and to remove the Shang Ring. Wound healing was assessed at 4 weeks postoperatively. RESULTS: Six hundred twenty-one men were enrolled, of whom 508 (81.8%) chose the Shang Ring and 113 the dorsal slit. The Shang Ring was provided to 504 men, among whom there were 4 failures of Ring placement (0.8%) that required surgical hemostasis and wound closure. Five hundred men received the Shang Ring and postoperative surgery-related moderate adverse events were 1.0%, compared with 0.8% among dorsal slit recipients. Complete wound healing at 4 weeks was 84% with the Ring and 100% with the dorsal slit (P < 0001). Resumption of intercourse before 4 weeks was 7.0% with the Ring and 15.0% with the dorsal slit (P = 0.01.) The mean time for surgery was 6.1 minutes with the Ring and 17.7 minutes with the dorsal slit. The mean time for Ring removal was 2.2 minutes. CONCLUSIONS: The Shang Ring is highly acceptable and safe in this setting, and could improve the efficiency of MMC services. However, back-up surgical services are needed in cases of Ring placement failures.
Authors: Mark A Barone; Frederick Ndede; Philip S Li; Puneet Masson; Quentin Awori; Jairus Okech; Peter Cherutich; Nicholas Muraguri; Paul Perchal; Richard Lee; Howard H Kim; Marc Goldstein Journal: J Acquir Immune Defic Syndr Date: 2011-05-01 Impact factor: 3.731
Authors: Mark A Barone; Quentin D Awori; Philip S Li; Raymond O Simba; Mark A Weaver; Jairus O Okech; Alex O Aduda; Peter Cherutich; Nicholas Muraguri; John Masasabi Wekesa; Jared Nyanchoka; Paul Perchal; Puneet Masson; Richard Lee; Marc Goldstein; Jackson Kioko; Ojwang' Lusi; David C Sokal Journal: J Acquir Immune Defic Syndr Date: 2012-07-01 Impact factor: 3.731
Authors: Ronald H Gray; Godfrey Kigozi; David Serwadda; Frederick Makumbi; Stephen Watya; Fred Nalugoda; Noah Kiwanuka; Lawrence H Moulton; Mohammad A Chaudhary; Michael Z Chen; Nelson K Sewankambo; Fred Wabwire-Mangen; Melanie C Bacon; Carolyn F M Williams; Pius Opendi; Steven J Reynolds; Oliver Laeyendecker; Thomas C Quinn; Maria J Wawer Journal: Lancet Date: 2007-02-24 Impact factor: 79.321
Authors: Robert C Bailey; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; John N Krieger; Carolyn F M Williams; Richard T Campbell; Jeckoniah O Ndinya-Achola Journal: Lancet Date: 2007-02-24 Impact factor: 79.321
Authors: Maria J Wawer; Frederick Makumbi; Godfrey Kigozi; David Serwadda; Stephen Watya; Fred Nalugoda; Dennis Buwembo; Victor Ssempijja; Noah Kiwanuka; Lawrence H Moulton; Nelson K Sewankambo; Steven J Reynolds; Thomas C Quinn; Pius Opendi; Boaz Iga; Renee Ridzon; Oliver Laeyendecker; Ronald H Gray Journal: Lancet Date: 2009-07-18 Impact factor: 79.321
Authors: Godfrey Kigozi; Ronald H Gray; Maria J Wawer; David Serwadda; Frederick Makumbi; Stephen Watya; Fred Nalugoda; Noah Kiwanuka; Lawrence H Moulton; Michael Z Chen; Nelson K Sewankambo; Fred Wabwire-Mangen; Melanie C Bacon; Renee Ridzon; Pius Opendi; Victor Sempijja; Absolom Settuba; Denis Buwembo; Valerian Kiggundu; Margaret Anyokorit; James Nkale; Nehemia Kighoma; Blake Charvat Journal: PLoS Med Date: 2008-06-03 Impact factor: 11.069
Authors: Richard Lee; E Charles Osterberg; Philip S Li; Marc Goldstein; Mark Barone; Stephanie L Combes; David Sokal; Ron Gray; Godfrey Kigozi; Stephen Watya Journal: J Acquir Immune Defic Syndr Date: 2013-10-01 Impact factor: 3.731
Authors: Stephanie M Davis; Helen Baker; Jessica M Gross; Sharon L Leslie; Cynthia M Z Chasokela; Julia Samuelson; Carlos Toledo Journal: J Assoc Nurses AIDS Care Date: 2021 Jan-Feb 01 Impact factor: 1.809
Authors: Stephen M Weiss; Robert Zulu; Deborah L Jones; Colleen A Redding; Ryan Cook; Ndashi Chitalu Journal: Lancet HIV Date: 2015-05 Impact factor: 12.767
Authors: Paul J Feldblum; Elijah Odoyo-June; Walter Obiero; Robert C Bailey; Stephanie Combes; Catherine Hart; Jaim Jou Lai; Shelly Fischer; Peter Cherutich Journal: PLoS One Date: 2014-05-01 Impact factor: 3.240